Powder: -20°C for 3 years | In solvent: -80°C for 1 year
ML198 is a novel activator and non-inhibitory chaperone of glucocerebrosidase. ML198 serves as a starting point to develop a novel approach towards small molecule treatment for patients suffering from Gaucher disease.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 76.00 | |
5 mg | In stock | $ 163.00 | |
10 mg | In stock | $ 263.00 | |
25 mg | In stock | $ 528.00 | |
50 mg | In stock | $ 769.00 | |
100 mg | In stock | $ 1,080.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 158.00 |
Description | ML198 is a novel activator and non-inhibitory chaperone of glucocerebrosidase. ML198 serves as a starting point to develop a novel approach towards small molecule treatment for patients suffering from Gaucher disease. |
Targets&IC50 | Glucocerebrosidase:0.4 μM (EC50) |
Molecular Weight | 290.32 |
Formula | C17H14N4O |
CAS No. | 1380716-06-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 2.9 mg/ml (10 mM), Sonification is recommended
H2O: Insoluble
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
ML198 1380716-06-2 Metabolism Glucokinase inhibit ML 198 GCase modulator Inhibitor Non-inhibitory chaperone ML-198 Gaucher disease Glucosidase Glucocerebrosidase inhibitor